七郎靜談美國

客觀介紹,多角度分析評價美國生活,政治,文化,藝術,體育等。
個人資料
  • 博客訪問:
文章分類
正文

HEALTH AND SCIENCE Nation’s testing czar: It’s ‘time to move on’

(2020-08-02 19:58:47) 下一個

我在這裏隻是提供一個不同的信息來自於不同的渠道,兼聽則明,偏信則暗。我一貫都會堅持建議大家能夠聽取多方麵的意見,才能明辨是非;聽信單方麵的話,就分不清是非。同時,在采取收集信息來源的時候,也要辨別提供信息來源人,來源地的背景,目的,和可信度等等基本的影響信息可信度的因素。比如是否有內在的利益衝突等等。

HEALTH AND SCIENCE

Nation’s testing czar: It’s ‘time to move on’ from talk about hydroxychloroquine

Adm. Brett Giroir, director of the U.S. coronavirus diagnostic testing, testifies during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Capitol Hill in Washington, U.S., June 30, 2020.

Adm. Brett Giroir, director of the U.S. coronavirus diagnostic testing, testifies during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Capitol Hill in Washington, U.S., June 30, 2020.

 

 

Brett Giroir, the assistant secretary for health who coordinates the administration’s coronavirus testing, said Sunday that there is no evidence that hydroxychloroquine is an “effective” treatment for COVID-19, despite President Donald Trump’s repeated boosting of the drug over objections from experts.

In an interview on “Meet the Press,” Giroir did not specifically mention the president, but he made clear that the scientific consensus is that the drug does not help treat the disease.

 

More from NBC News:

Southern California wildfire forces thousands to evacuate

Rep. Karen Bass, potential VP pick, addresses her past praise of Scientology

NASA astronauts scheduled return to Earth via SpaceX capsule is a ‘go’

“Most physicians and prescribers are evidence-based and they’re not influenced by whatever is on Twitter or anything else. And the evidence just does not show hydroxychloroquine is effective right now,” he said.

“We need to move on from that and talk about what is effective,” he added, pointing to public hygiene measures like hand-washing and mask-wearing, as well as treatments like the drug remdesivir and steroids.

“At this point in time, there has been five randomized controlled, placebo controlled trials that do not show any benefit to hydroxychloroquine. So, at this point in time, we don’t recommend that as a treatment.”

Since the early days of the pandemic, Trump has promoted his belief that hydroxychloroquine, an anti-malarial drug, could help treat the disease. In May, he said he took the unproven treatment for two weeks prophylactically.

 

While the Food and Drug Administration briefly issued the drug an emergency use authorization that allowed it to be used as treatment for COVID-19, the FDA withdrew that authorization in June. In removing the authorization, it pointed to “a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery.”

Despite similar statements from public health officials, as well as an FDA warning against using the drug outside of a hospital setting because of a risk of serious heart problems, Trump has remained steadfast in boosting of the drug.

Last week, Trump retweeted a video of a Houston-area doctor arguing in favor of using the drug and calling it a cure for coronavirus. Twitter removed the video calling it “in violation of our COVID-19 misinformation policy” and Dr. Anthony Fauci, the nation’s top infectious disease expert, said the video was “spouting something that isn’t true.”

But Trump defended his decision to share the video during a White House press briefing, saying, “I happen to believe in it.” He was later pressed to answer for the doctor’s past statements, which include blaming certain medical problems on demonic possession.

“She was on air along with many other doctors,” Trump said. “They were being fans of hydroxychloroquine, and I thought she was very impressive in the sense that — from where she came, I don’t know which country she comes from — but she said that she’s had tremendous success with hundreds of different patients, and I thought her voice was an important voice. But I know nothing about her.”

[ 打印 ]
閱讀 ()評論 (0)
評論
目前還沒有任何評論
登錄後才可評論.